Results 141 to 150 of about 14,810 (242)

Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study [PDF]

, 2014
Emily M. McMurray, I. R. Wallace, C. N. Ennis, Steven Hunter, A. B. Atkinson, P. M. Bell   +5 more
openalex   +1 more source

The effect of eplerenone in chronic central serous chorioretinopathy refractory to PDT therapy [PDF]

, 2018

openalex   +1 more source

Eplerenone [PDF]

, 2020
openaire   +1 more source

Evaluation of Pharmacokinetics and Tolerability of Eplerenone after Multiple Oral Doses of 100 mg in Healthy Korean Volunteers [PDF]

, 2011
SeongHae Yoon, SeungHwan Lee, Dal‐Seok Oh, Kyoung Soo Lim, Sang-Goo Shin, In‐Jin Jang, Kyung Sang Yu   +6 more
openalex   +1 more source

The Role of Aldosterone in Vascular Permeability in Diabetes. [PDF]

Cells
Aleksiejczuk M, Bielicka N, Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Mierzejewska P, Stelmaszewska J, Dzieciol J, Chabielska E, Gromotowicz-Poplawska A.   +9 more
europepmc   +1 more source

Effect of polymers on in-vitro performance of eplerenone sustained release matrix tablets

, 2012
Madhusudan Rao Yamsani, Sunil K. Reddy, Vinay Kumar Katakam, Jaganmohan Somagoni, Pavan Panakanti, Sathish Dharani   +5 more
openalex   +1 more source

Evaluation of Changes in Optical Coherence Tomography (OCT) Biomarkers After Oral Eplerenone Therapy in Chronic Central Serous Chorioretinopathy and Their Correlation to Functional Visual Outcome. [PDF]

Cureus
Mishra P, Moharana B, Palanisamy S, Nayak B, Panda BB, Sahu SK, Parija S.   +6 more
europepmc   +1 more source

Finerenone vs eplerenone for patients with HFrEF [PDF]

, 2016
Karina Huynh
openalex   +1 more source

FORMULATION, OPTIMIZATION, AND CHARACTERIZATION OF TRANSDERMAL DRUG DELIVERY SYSTEMS CONTAINING EPLERENONE

, 2022
Ramesh Shinde, Malarkodi Velraj
openalex   +2 more sources

Oral Eplerenone for Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report. [PDF]

Cureus
Paliwal S, Upadhaya P, Thakar S.
europepmc   +1 more source